{"id":"W2745845806","doi":"10.1093/rheumatology/kex301","title":"Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study","year":2017,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Secukinumab; Medicine; Placebo; Dactylitis; Psoriatic arthritis; Tolerability; Adverse effect; Internal medicine; Psoriasis Area and Severity Index; Randomized controlled trial; Psoriasis; Enthesitis; Rheumatoid arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001888568,0.000155827,0.0003749419,0.00003270017,0.0002163382,0.00004500829,0.0001346644,0.00005745395,0.00002387599],"category_scores_gemma":[0.000130223,0.0001078667,0.00005258974,0.00005211602,0.0000883822,0.00007038422,0.0001448602,0.0001420017,0.000005565924],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004833378,"about_ca_system_score_gemma":0.00003914957,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001846232,"about_ca_topic_score_gemma":0.002609251,"domain_scores_codex":[0.9988768,0.00003675769,0.0003195132,0.0002994612,0.0002402345,0.0002272176],"domain_scores_gemma":[0.9989372,0.0000680551,0.000174364,0.0006986999,0.00005743044,0.00006422405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.005427286,0.006888592,0.4522991,0.00007088821,0.00168881,0.001886392,0.03229064,0.000001265169,0.0009230257,0.0003400464,0.001601413,0.4965825],"study_design_scores_gemma":[0.1105642,0.009617971,0.846374,0.0003946198,0.0003188036,0.000009550286,0.02714538,0.00002601945,0.0002744143,0.0003431145,0.004687606,0.0002443826],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949728,0.001850726,0.000001004066,0.0009220798,0.0002400525,0.001090834,0.0003316427,0.0000144028,0.0005764101],"genre_scores_gemma":[0.9987872,0.0004951095,0.00003721156,0.00008444352,0.0003449273,0.0000565401,0.00004816056,0.0000158496,0.0001305401],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4963381,"threshold_uncertainty_score":0.4398678,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01221630008356113,"score_gpt":0.2854264743297102,"score_spread":0.2732101742461491,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}